BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28506688)

  • 41. Utility of fungal blood cultures for patients with AIDS.
    Mess T; Daar ES
    Clin Infect Dis; 1997 Dec; 25(6):1350-3. PubMed ID: 9431376
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epidemiology of invasive fungal infections in patients with acquired immunodeficiency syndrome at a reference hospital for infectious diseases in Brazil.
    de Oliveira RB; Atobe JH; Souza SA; de Castro Lima Santos DW
    Mycopathologia; 2014 Aug; 178(1-2):71-8. PubMed ID: 24952013
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty-first century.
    Walsh TJ; Groll AH
    Transpl Infect Dis; 1999 Dec; 1(4):247-61. PubMed ID: 11428996
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prophylaxis against Pneumocystis carinii pneumonia among children with perinatally acquired human immunodeficiency virus infection in the United States. Pneumocystis carinii Pneumonia Prophylaxis Evaluation Working Group.
    Simonds RJ; Lindegren ML; Thomas P; Hanson D; Caldwell B; Scott G; Rogers M
    N Engl J Med; 1995 Mar; 332(12):786-90. PubMed ID: 7862183
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endemic fungal infections caused by Cryptococcus neoformans and Penicillium marneffei in patients infected with human immunodeficiency virus and treated with highly active anti-retroviral therapy.
    Sun HY; Chen MY; Hsiao CF; Hsieh SM; Hung CC; Chang SC
    Clin Microbiol Infect; 2006 Apr; 12(4):381-8. PubMed ID: 16524416
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incidence of acquired immunodeficiency syndrome-associated opportunistic diseases and the effect of treatment on a cohort of 1115 patients infected with human immunodeficiency virus, 1989-1997.
    San-Andrés FJ; Rubio R; Castilla J; Pulido F; Palao G; de Pedro I; Costa JR; del Palacio A
    Clin Infect Dis; 2003 May; 36(9):1177-85. PubMed ID: 12715314
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recommendations for fungal opportunistic infections prevention in persons infected with human immunodeficiency virus.
    Popa LG; Popa MI; Zaharia A; Ocneanu M
    Roum Arch Microbiol Immunol; 1999; 58(2):185-95. PubMed ID: 11845456
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HIV and the lung.
    Wallace JM
    Curr Opin Pulm Med; 1998 May; 4(3):135-41. PubMed ID: 9675515
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changing patterns and trends in systemic fungal infections.
    Richardson MD
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i5-i11. PubMed ID: 16120635
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pulmonary infections in HIV infected patients.
    Mootsikapun P; Chetchotisakd P; Intarapoka B
    J Med Assoc Thai; 1996 Aug; 79(8):477-85. PubMed ID: 8855629
    [TBL] [Abstract][Full Text] [Related]  

  • 51. I hear you knockin' (but you can't come in): potent new HIV therapies are shutting out opportunistic infections.
    Fichtenbaum CJ
    Res Initiat Treat Action; 1998 Jul; 4(4):3-7. PubMed ID: 11365645
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Profile of opportunistic infections in HIV-infected patients at a tertiary care center in Lebanon.
    Naba MR; Kanafani ZA; Awar GN; Kanj SS
    J Infect Public Health; 2010; 3(3):130-3. PubMed ID: 20869674
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E
    Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sepsis predisposition in children with human immunodeficiency virus.
    Hatherill M
    Pediatr Crit Care Med; 2005 May; 6(3 Suppl):S92-8. PubMed ID: 15857567
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Community-acquired pneumonia in HIV-infected children: a global perspective.
    Gray DM; Zar HJ
    Curr Opin Pulm Med; 2010 May; 16(3):208-16. PubMed ID: 20375782
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunopathogenesis of Pneumocystis carinii pneumonia.
    Gigliotti F; Wright TW
    Expert Rev Mol Med; 2005 Nov; 7(26):1-16. PubMed ID: 16842636
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fungal infections in immunocompromised travelers.
    Lortholary O; Charlier C; Lebeaux D; Lecuit M; Consigny PH
    Clin Infect Dis; 2013 Mar; 56(6):861-9. PubMed ID: 23175562
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oral candidiasis in pediatric HIV patients.
    Lal S; Chussid S
    N Y State Dent J; 2005 Mar; 71(2):28-31. PubMed ID: 15887466
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effectiveness of twice-weekly pyrimethamine-sulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection.
    Schürmann D; Bergmann F; Albrecht H; Padberg J; Wünsche T; Grünewald T; Schürmann M; Grobusch M; Vallée M; Ruf B; Suttorp N
    Eur J Clin Microbiol Infect Dis; 2002 May; 21(5):353-61. PubMed ID: 12072919
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recent progress in the diagnosis of fungal infections in the immunocompromised host.
    Erjavec Z; Verweij PE
    Drug Resist Updat; 2002 Feb; 5(1):3-10. PubMed ID: 12127859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.